6th Jun 2008 11:00
This announcement replaces the announcement released on 18 April 2008 at 14:58, RNS No: 6831S.
The Administrators of the accounts of the under-mentioned persons advised the Company on 5 June 2008 of a correction to the number of Ordinary dividends re-invested on 10 April 2008 in respect of the under-mentioned persons.
All other details remain unchanged.
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares at a price of £10.73 per share and Ordinary share ADRs at a price of $43.32 per ADR in GlaxoSmithKline plc in respect of the personal holdings of the under-mentioned persons, following the re-investment of the dividend paid to shareholders on 10 April 2008.
|
Ordinary shares |
ADRs |
|
|
Dr M M Slaoui |
28.86 |
|
|
Mrs C E Bruck Slaoui |
16.49 |
|
|
Mr EJ Gray |
29.47 |
|
|
Mr D Learmouth |
27.80 |
|
|
Mr W C Louv |
14.19 |
|
|
Mr S M Werner |
14.47 |
The Company and the above named persons were advised of this information on 18 April 2008.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
18 April 2008
Related Shares:
Glaxosmithkline